Amyloid-β accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism
10.1186/s12974-023-02722-z · doi-reference
Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity
10.1186/s40035-025-00474-9 · doi-reference
Astrocytic induction of triglyceride lipolysis in AD-associated pathology and neuroinflammation
10.1002/alz.093056 · doi-reference
BACE1 regulates expression of clusterin in astrocytes for enhancing clearance of β-amyloid peptides
10.1186/s13024-023-00611-w · doi-reference
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease
10.1038/s41591-019-0695-9 · doi-reference
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
10.1038/s41467-020-19264-0 · doi-reference
The contribution of activated astrocytes to Aβ production: implications for Alzheimer’s disease pathogenesis
10.1186/1742-2094-8-150 · doi-reference
Aβ oligomers promote lipid droplet accumulation and inflammatory responses in astrocytes but not neurons
10.1016/j.brainresbull.2025.111556 · doi-reference
Fear learning induces α7-nicotinic acetylcholine receptor-mediated astrocytic responsiveness that is required for memory persistence
10.1038/s41593-021-00949-8 · doi-reference
Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains
10.1001/jamaneurol.2016.4370 · doi-reference
APOE effects on regional tau in preclinical Alzheimer’s disease
10.1186/s13024-022-00590-4 · doi-reference
Glial GABA, synthesized by monoamine oxidase B, mediates tonic inhibition
10.1113/jphysiol.2014.278754 · doi-reference
Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis
10.1186/s13024-025-00796-2 · doi-reference
C1q/TNF-related protein 4 restores leptin sensitivity by downregulating NF-κB signaling and microglial activation
10.1186/s12974-021-02167-2 · doi-reference
IKK2/NF-κB activation in astrocytes reduces amyloid β deposition: a process associated with specific microglia polarization
10.3390/cells10102669 · doi-reference
Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
10.1186/s12974-020-01930-1 · doi-reference
AQP4 association with amyloid deposition and astrocyte pathology in the Tg-ArcSwe mouse model of Alzheimer’s disease
10.3233/jad-160957 · doi-reference
The current agonists and positive allosteric modulators of α 7 nAChR for CNS indications in clinical trials
10.1016/j.apsb.2017.09.001 · doi-reference
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
10.1038/s41582-019-0228-7 · doi-reference
Vimentin immunoreactivity in normal and pathological human brain tissue
10.1007/bf00311389 · doi-reference
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits
10.1186/s13024-015-0056-1 · doi-reference
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases
10.1126/scitranslmed.abe5640 · doi-reference
Disruption of BAG3-mediated BACE1 stabilization alleviates neuropathology and memory deficits in a mouse model of Alzheimer’s disease
10.1126/sciadv.adt7981 · doi-reference
Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer’s disease
10.1039/d0fo00161a · doi-reference
Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy
10.1016/j.celrep.2019.07.060 · doi-reference
Multiscale proteomic modeling reveals protein networks driving Alzheimer’s disease pathogenesis
10.1016/j.cell.2025.08.038 · doi-reference
Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia
10.1016/j.neuron.2021.03.024 · doi-reference
Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer’s brain: Aβ-degrading enzymes profiling in Alzheimer’s brain
10.1111/j.1471-4159.2010.06899.x · doi-reference
β-Amyloid1–42 binds to α7 nicotinic acetylcholine receptor with high affinity
10.1074/jbc.275.8.5626 · doi-reference
Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex
10.1038/s41467-020-20322-w · doi-reference
The accumulation of tau-immunoreactive hippocampal granules and corpora amylacea implicates reactive glia in tau pathogenesis during aging
10.1016/j.isci.2020.101255 · doi-reference
Calcium-dependent signaling in astrocytes: downstream mechanisms and implications for cognition
10.1111/jnc.70019 · doi-reference
The role of sphingosine 1-phosphate metabolism in brain health and disease
10.1016/j.pharmthera.2023.108381 · doi-reference
Astrocytes and microglia: in sickness and in health
10.1016/j.tins.2020.01.003 · doi-reference
Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection
10.1111/jnc.14064 · doi-reference
Evaluation of 11C-BU99008, a positron emission tomography ligand for the Imidazoline2 binding site in human brain
10.2967/jnumed.118.208009 · doi-reference
Fibroblast growth factor signalling: from development to cancer
10.1038/nrc2780 · doi-reference
Bridging regional neurovascular unit heterogeneity and cognitive function: a review
10.1186/s12987-025-00697-y · doi-reference
Astrocytic GLUT1 deletion in adult mice enhances glucose metabolism and resilience to stroke
10.1038/s41467-025-59400-2 · doi-reference
Adenosine signalling to astrocytes coordinates brain metabolism and function
10.1038/s41586-024-07611-w · doi-reference
